Creative Biolabs is a leading oncology NGS provider, offering complete, high-throughput whole-genome analysis and expert bioinformatics to accelerate cancer research and personalized treatment.
Learn More →Weighted Gene Co-expression Network Analysis (WGCNA) based Longevity Gene RNA-Seq Data Analysis Service
Creative Biolabs' weighted gene co-expression network analysis (WGCNA) based longevity gene RNA-seq data analysis service provides a critical systems-level perspective that moves beyond analyzing isolated genes. We focus on identifying the coordinated genetic modules that either collapse during aging or are maintained in long-lived organisms, directly linking network integrity to phenotypic outcomes. This allows for the precise identification of interventions that stabilize or restore youthful network function.
Background What We Can Offer Workflow Publication Why Choose Us FAQs Customer Review Related Services Contact Us
The Paradigm Shift: From Single Genes to System Dynamics
For decades, longevity research—the pursuit of understanding and extending healthspan—has focused on a reductionist approach, identifying single genes or discrete pathways (like mTOR or sirtuins) that influence lifespan. While valuable, this methodology often overlooks the sheer complexity of the aging process, which is fundamentally driven by the dynamic collapse of interwoven gene regulatory networks (GRNs). Furthermore, the study of exceptional longevity and robust stress resistance (such as response to oxidative or cold stress) reveals that these traits are governed by the same underlying metabolic and protective pathways.
Our Solutions: WGCNA-Based Longevity Gene Analysis
Phenotype-Specific Module Identification and Decryption
We use WGCNA to identify gene modules statistically correlated with specific longevity traits (lifespan, healthspan, stress resistance).
Pinpointing Master Regulator (Hub) Genes
We identify highly connected hub genes within significant modules, representing optimal therapeutic targets.
Validation-Ready Outcomes
Our outputs provide statistical confirmation and functional annotations for immediate experimental validation (e.g., siRNA, CRISPR).
Discover How We Can Help - Request a Consultation to map the core genetic networks driving longevity in your model and secure your next generation of high-value targets.
Workflow
Our robust, five-stage process is meticulously designed for clarity, efficiency, and maximum biological insight, facilitating easy visualization as a comprehensive project flowchart.
Publication
This study used WGCNA on RNA-seq data to investigate varicose vein (VV) transcriptomic mechanisms. Comparing VV to control veins, four gene modules were identified. Key findings showed a module enriched for inflammatory/immune responses and another linked to skeletal myofibril assembly.1 Histopathological analysis confirmed increased wall thickness and altered collagen. Notably, the NLRP3 inflammasome was downregulated. The study concludes that WGCNA effectively highlighted the potential role of skeletal myofibril assembly in VV pathogenesis, providing novel therapeutic targets.
Fig.1 Construction of four gene co-expression networks using WGCNA. 1
Why Choose Us?
Creative Biolabs applies WGCNA with a crucial systems biology focus, ensuring delivered targets are true network orchestrators—not just differentially expressed genes. We achieve exceptional precision and high-confidence target prioritization through iterative soft-thresholding and rigorous integration of quantitative phenotypic data. This approach ensures robust network topology, minimizes false positives, and provides clients with a significant increase in target identification confidence and a measurable reduction in unnecessary validation costs. Our methodology guarantees the most therapeutically relevant targets for your drug discovery program.
Experience the Creative Biolabs Advantage - Get a Quote Today
FAQs
Q1: How does WGCNA compare to simple analysis for identifying master drug targets?
A1: WGCNA identifies networks (modules) of functionally coordinated genes. This systemic approach is superior because it reveals the master switch hub genes that control entire pathways, providing higher-confidence and significantly more impactful therapeutic targets.
Q2: What kind of input data is compatible with the Creative Biolabs WGCNA longevity service?
A2: We primarily work with high-quality RNA-seq data (raw or normalized count matrices) derived from relevant aging models or human cohorts. To maximize the biological relevance of the output, we strongly encourage the submission of corresponding quantitative phenotypic or physiological data.
Q3: Will the WGCNA analysis help me understand if my drug intervention has a systemic or pathway-specific impact?
A3: Yes, this is one of its core advantages. WGCNA allows us to identify how gene networks are preserved or destabilized across different conditions. By comparing module preservation, we can prove whether your intervention is having a broad, systemic, and therapeutic effect or a localized, minor one.
Customer Review
-
MAPT Network Discovery
The results confirmed our suspicion that simple DEG analysis was missing the coordinated downregulation of critical synaptic genes. The module structure gave us the high-confidence network we needed, vastly superior to a static gene list. – Jn*Smh -
Structural Insight Validation
Their finding pointed directly to skeletal myofibril assembly—a structural mechanism we hadn't prioritized. This single insight focused our subsequent IHC and qPCR efforts, saving us months of costly trial-and-error validation. – Km*Lee
Related Services
To fully leverage the power of WGCNA, customers often require complementary services from Creative Biolabs to complete the discovery and validation cycle.
NGS based Genome Sequencing Service
Ferroptosis Tumor-related Pathway Solutions
Creative Biolabs focuses on ferroptosis innovation for oncology. We offer comprehensive products and services to explore this DNA damage pathway, a novel avenue for cancer therapy.
Learn More →How to Contact Creative Biolabs
The next generation of anti-aging therapies will target the emergent properties of gene networks, not isolated components. Partner with Creative Biolabs to leverage the power of WGCNA and transform your raw RNA-Seq data into a detailed, actionable map of the human longevity circuitry.
Reference
- Zhang, Jianbin, et al. "Weighted Gene Co-expression Network Analysis for RNA-Sequencing Data of the Varicose Veins Transcriptome." Frontiers in Physiology 10 (2019). Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fphys.2019.00278
Download our brochureLoading case studies...
Online Inquiry